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The immune response of inbred strains of mice to the random terpolymer L-glutamic 
acid6°-L-alanine3°-L-tyrosine  l° (GAT)  l is controlled by a  specific immune response (It) 
gene which maps in the I region of the 11-2 complex between the K and S regions (1-3). 
In previous reports in this series, we have described a  technique for the detection of 
primary GAT-specific IgG plaque-forming cell (PFC) responses in mouse spleen  cell 
cultures  (4).  Spleen  cells  from  both  responder  (11-2".  b, a, k)  and  non-responder 
(11-2 p' q. ~) mice develop IgG PFC responses specific for  GAT after  incubation with 
GAT complexed  to  the  immunogenic  carrier  methylated  bovine  serum  albumin 
(GAT-MBSA), but only spleen cells from  responder mice develop GAT-specific IgG 
PFC  responses to GAT. 
The  immune  responses  to  GAT  and  GAT-MBSA  are  thymus  dependent  (5). 
Furthermore, spleen cells from  GAT-primed, irradiated responder mice were  shown 
to  have  GAT-specific helper  T-cell  function,  while  no  GAT-specific helper  T-cell 
function could be demonstrated in spleen cells from  GAT-primed, irradiated nonre- 
sponder mice (5). These data suggest that the defect in genetic nonresponder mice is 
the failure of their T  cells, after interaction with GAT, to provide appropriate helper 
T-cell function for the initiation of the B-cell response to GAT. 
More recently, we have observed that injection of GAT not only fails to elicit a 
GAT-specific PFC response in nonresponder mice, but also specifically decreases the 
ability of nonresponder mice to develop a GAT-specific PFC response to a subsequent 
challenge with GAT-MBSA (6). Addition of soluble GAT to cultures of spleen cells 
from  nonresponder  mice  also  prevents  development  of  the  GAT-specific response 
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stimulated by GAT-MBSA. Thus, GAT is recognized by nonresponder mice, but this 
recognition leads to specific tolerance rather than immunity. 
To  analyze the mechanism  involved in tolerance induced by GAT in non- 
responder mice, we have investigated: (a) the immunocompetence  of T  and  B 
cells from spleens of nonresponder mice previously rendered unresponsive by 
injection of GAT; and (b) the effects of such  populations of T  and  B  ceils on 
the development of GAT-specific PFC responses by normal nonresponder spleen 
cells incubated with GAT-MBSA. 
Materials and Methods 
Mice 
DBA/1 (//-2  q) mice were purchased from Jackson Laboratories, Bar Harbor, Maine. Mice 
used in these experiments were 2-8-mo old and were maintained on laboratory chow and acidi- 
fied-chlorinated water ad libitum. 
Antigens 
GAT, tool wt 32,000, was purchased from Miles Laboratories~ Inc., Miles Research Div., 
Kankakee, Ill. Methylated bovine serum  albumin (MBSA)  was prepared according to the 
method of N. Sueoka, and Ts'ai-Ying Cheng  (7). Preparations of SRBC, GAT, and GAT- 
MBSA for addition to cultures have been described previously (4). 107 SRBC or GAT-MBSA 
containing 5/zg GAT and/or various amounts of soluble GAT were added to cultures according 
to the experimental protocol. 
Immunization  of Mice 
Mice were injected intraperitoneally  with 10 #g GAT-MBSA in a mixture of Maalox (Win. 
H. Rorer, Inc., Fort Washington, Pa.) and pertussis vaccine  (Eli Lilly & Co., Indianapolis, 
Ind,) as previously described (1). Mice were immunized with GAT as indicated in the experi- 
mental protocol. 
Spleen Cell Cultures and PFC Assay 
Suspensions of single spleen ceils containing 10 ×  106 nucleated cells in culture medium 
(MEM) were incubated according to the method of Mishell and Dutton (8) with modifica- 
tions previously described (9). GAT coupled to SRBC with CrCla were used as indicator cells 
in the hemolytic plaque assay as described previously (4). 
Sources of B and T Cells 
Populations of splenic T and B cells were prepared by two methods: column fractionation 
and depletion. 
Column Fractionation.-- 
Preparation of immunoabsorbent columns:  Mouse Fab was prepared from a pepsin digest 
of mouse Ig, emulsified in complete Freund's adjuvant, and used to immunize rabbits for the 
production of antimouse Fab. The resulting antisera were purified over Sepharose 4B mouse-Ig 
immunoabsorbent columns, concentrated, dialyzed, and stored at -20°C. The purified anti- 
body was conjugated to cyanogen bromide-activated Sephadex G-200 by methods previously 
described  (10). Approximately 0.3  nag  of  antibody was routinely bound/ml  of activated 
Sephadex.  12-ml disposable  syringes  are fitted with polyethylene discs  (Bel-Art Products, 
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washed with media 199  (Grand Island Biological Co., Grand Island, N. Y.) containing 5% 
fetal calf sera  (FCS),  2.5  mM  EDTA,  1%  penicillin-streptomycin solution,  incubated  at 
37°C for 60 rain,  and returned to 4°C for cell fractionation. 
Cell preparation and fractionation:  Mouse  spleen cells were teased into the above media 
without EDTA, aggregates sedimented, and the resulting single cell suspension treated  with 
iron carbonyl at 37°C for 30 rain. The phagocytic cells were removed in a magnetic field as pre- 
viously described (10). Cells were resuspended in EDTA containing media and placed on  the 
column in a concentration of approximately 20  X  10 n cells/ml. The cells were applied to  the 
column at 4°C and collected by stepwise elution with 15-ml  aliquots of EDTA  containing 
starting media at a flow rate of 0.5 ml/min until the effluent was  cell-free.  The  bound  cells 
were eluted by competitive inhibition using 2 X  15-ml aliquots of media containing 10% autol- 
ogous mouse sera as a source of gamma globulin. 9. 
Analysis of surface characteristics:  Unfractionated,  nonretained,  and  serum-eluted  cell 
populations were studied with respect to surface Ig properties. The presence of surface Ig's was 
detected by using a direct fluoresceinated antibody technique. To approximately 2 X  106 ceils 
was added 0.1 ml of fluoresceinated antimouse Fab and the reaction mixture incubated at 4°C 
for 30 min. The cells were then washed three times with cold PBS containing 10% FCS and 
suspended  in a  glycerol-phosphate-buffered saline buffer and  viewed with a  Zeiss  Universal 
fluorescense  microscope (Carl Zeiss, Inc., New York) with an Osram 100 watt ultraviolet fight 
source and with phase contrast. Routinely 200 viable cells were counted on the phase contrast 
and percentage staining with fluoresceinated antisera enumerated. Control fluorescein reagents 
consisting of fluoresceinated rabbit gamma globulin were used and in these experiments stained 
less than 2% of the cells. 
Depletion.-- 
Theta-bearing cells were depleted from normal spleen cell suspensions  by treatment with 
appropriate concentrations of anti-0 C3H serum and a  1:3 dilution of guinea pig serum as a 
source of C before culture initiation. As a control, a fraction of the spleen cell suspension was 
treated with C alone. After treatment, 10 ×  106 cells in MEM were added to cultures with or 
without additional cells and  SRBC or GAT-MBSA or GAT according to the experimental 
protocol. The helper cell function of antigen-primed  T  cells has  been demonstrated  to be 
radioresistant, whereas B cells and normal T cells are radiosensitive (11, 12). Therefore, mice 
primed with GAT-MBSA 1--4 mo earlier were X  irradiated with 700-800 R as previously de- 
scribed (5). Within 3 h after irradiation, the mice were sacrificed  and single cell suspensions 
were prepared from their spleens.  10 X  l0 s cells in MEM were added to cultures with or with- 
out additional cells and GAT or GAT-MBSA as indicated in the experimental protocol. 
RESULTS 
Immunocompetence  of Spleen Cells from DBA /1 Mice Primed with GA T.--The 
responsiveness  of spleen  cells from  normal  and  GAT-primed  DBA/1  mice  to 
SRBC  and  GAT-MBSA  was  compared in vitro. The results  (Table I)  demon- 
strate  that  spleen  cells  from  normal  DBA/1  mice  develop  PFC  responses  to 
SRBC  (group A) and to GAT-MBSA  (group B). In contrast,  spleen cells from 
mice injected with 10 #g GAT in Maalox-pertussis  15 days before culture initia- 
tion fail to develop a  GAT-specific PFC  reponse to GAT-MBSA  (group D), al- 
though  they  respond  normally  to  SRBC  (group  C).  Thus,  removal  of spleen 
9. Chess, L., R. P. MacDermott, and S. F. Sehlossman. 1974. Immunologic functions of iso- 
lated human  lymphocyte subpopulations  I. Quantitative isolation of human T  and  B  cells 
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TABLE I 
Restoration of the GA T-Spedf~ PFC Response in Cultures of Tolerant Spleen  Cells by Irradiated 
GA T-MBSA-Primed Spleen  Cells 
DBA/t spleen cells  IgG PFC/culture* 
107 Irradiated 
107  107 GAT-primedl:  GAT-MBSA  Antigen  SRBC  GAT  G~mp  Normal  primed§ 
A  +  -- 
B  +  -- 
C  -  + 
D  --  + 
107 An~i-O and C treated 
E  +  -- 
F  --  -- 
G  +  - 
H  +  + 
I  --  + 
B 
m 
SRBC  1,240  -- 
GAT-MBSA  --  1,480 
SRB C  1,540  -- 
GAT-MBSA  --  < 10 
--  GAT-MBSA  --  < 10 
+  GAT-MBSA  --  6O 
+  GAT-MB SA  -  3 , 460 
--  GAT-MBSA  -  180 
+  GAT-MBSA  --  1,690 
* Cultures harvested after 5 days incubation with l0  T  SRBC or 5 #g GAT as GAT-MBSA. 
:~ Mice primed with 10 #g GAT in Maalox-pertussis 15 days before culture initiation. 
§ Mice primed with GAT-MBSA containing 10#g GAT in Maalox-pertussis 32 days before 
X irradiation  (800 R) and culture initiation. 
cells from the environs of the tolerant mouse (6) does not reverse this GAT-spe- 
cific unresponsiveness. 
Normal B  cells or spleen cells from GAT-MBSA-primed, irradiated  DBA/1 
mice (T cells) were added to cultures of spleen cells from GAT-primed DBA/1 
mice to determine the immunocompetence of B  and T  cells from tolerant mice. 
B  cells, prepared by treatment of normal spleen cells with anti-0 serum and C, 
and GAT-MBSA-primed, irradiated T  cells did not develop GAT-specific PFC 
responses when  cultured separately  with  GAT-MBSA  (groups E  and  F),  but 
developed a GAT-specific response when cultured together with antigen (group 
G) showing that both populations were functional. Addition of normal B  cells 
to GAT-primed spleen cells (group H) failed to restore responsiveness to GAT- 
MBSA. Thus, the specific unresponsiveness of these spleen cells is not due merely 
to an inactivation or elimination of GAT-specific B cells by in vivo exposure to 
GAT.  If  that  were  the  case,  normal  B  cells  should  cooperate  with  carrier 
(MBSA)-specific T  cells present  in  the  spleen  cells of GAT-primed mice and 
such cultures would be expected to develop a PFC response to GAT-MBSA. 
Addition of 107 irradiated  GAT-MBSA-primed helper T  cells to cultures of 
otherwise unresponsive spleen cells from GAT-primed mice did restore the GAT- 
specific immune response  to GAT-MBSA (group I). Thus, B  cells from unre- 
sponsive mice are not themselves unresponsive, but can be induced to develop a 
GAT response  to GAT-MBSA provided additional  MBSA helper  T  cells  are 
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sponder mice unable  to provide adequate helper cell function for the  B-cell 
response. 
Suppressive Activity of Spleen Cells from GA T-Primed DBA /1 Mice.--Since it 
seemed improbable that GAT could render some carrier-specific helper T  cells 
(MBSA-specific) inactive while leaving others (e.g., SRBC specific) intact, we 
examined spleen cells from GAT-primed mice for active suppressor cells. Spleen 
cells from such mice were added to cultures of spleen cells from normal DBA/1 
mice and the immune response to GAT-MBSA measured. The results of two 
such experiments (Table II) show that spleen cells from GAT-primed mice not 
only failed to respond to GAT-MBSA in culture (group A) but also suppressed 
the development of a GAT-specific PFC response of normal DBA/1 spleen cells 
TABLE II 
Effect of Tolerant DBA /1 Spleen Cells on the Immune Response by Normal DBA /1 Spleen Cells 
In Vitro 
DBA/1 spleen  cells  IgG GAT-specific PFC/culture* 
Group 
10  7  Normal  10  ¢ GAT- primed$  Exp. I  Exp. 2 
A  --  +  < 10  80 
B  +  --  560  1,2O3 
C  +§  --  830  ND 
D  +  +  110  40O 
E  +  +[I  330  1,0O0 
* PFC response after 5 days in culture with 5 #g GAT as GAT-MBSA. 
:~ Mice injected with 10 #g GAT in Maalox 3 days (exp. 1) or 4 days (exp. 2) before culture 
initiation. 
§ 2 ×  10  ~  normal spleen  cells. 
IJ Treated with anti-0 serum and C. 
stimulated with GAT-MBSA (compare groups B and D). It is unlikely that this 
suppression is due to a detrimental effect of increased cell density since 2 X  10  T 
normal  DBA/1  spleen cells  (group  C)  responded  even better  than  1  X  l0  T 
spleen cells (group B). Thus, the failure of GAT-primed spleen cells to respond 
to GAT-MBSA involves an active suppression. Treatment of spleen cells from 
GAT-primed DBA/1 mice with anti-0 serum and C before culture initiation sig- 
nificantly reduced but did not abolish the suppressive activity which these cells 
exerted on the response of normal spleen cells (group E). 
Radiosensitivity of Suppressor T Cells.--The ability of spleen cells from GAT- 
primed DBA/1 mice exposed to 800 R X  irradiation 3 h before sacrifice to sup- 
press the normal DBA/1 spleen cell response to GAT-MBSA was compared to 
the suppressive ability of spleen cells from unirradiated GAT-primed mice. The 
results  (Table III) demonstrate that suppressor cell  activity is radiosensitive 
11 days after GAT priming (group G vs. H). 
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TABLE III 
Radiation Sensitivity  of Suppressor  T Cells 
DBA/I spleen  cells  IgG 
Group  107 Normal  10  7 GAT-  107 X irradiated  Antigen  GAT-specifie 
primed*  GAT-primedt  PFC/culture§ 
A  +  -  --  GAT  < 10 
B  +  --  --  GAT-MBSA  525 
C  --  +  --  GAT  15 
D  --  +  --  GAT-MBSA  10 
E  --  --  +  GAT-MBSA  <10 
F  + 11  --  --  GAT-MBSA  625 
G  +  +  -  GAT-MBSA  < 10 
H  +  --  +  GAT-MBSA  655 
* Spleen cells from mice immunized with 10 #g GAT in Maalox, 11 days before sacrifice. 
:~ Same as above, except mice given 800 R X irradiation 3 h before sacrifice. 
§ Cultures harvested after 5 days with 5/zg GAT or 5/zg GAT as GAT-MBSA. 
[[ 2 )< 107 normal DBA/1 spleen cells. 
Fractionated  on  a  Dextran  Column  Specific for Fab  of Mouse Ig.--To  directly 
assess the properties of T  and B  cells from GAT-primed DBA/1  mice, spleen 
cells were  fractionated  by passage  over  a  Sephadex  G-200  column  to  which 
rabbit antimouse  Fab  antibodies had been  coupled.  Cells which  do  not  bear 
membrane Ig's are not bound to such a  column. The cell fraction which passes 
through the column contains all the 0-bearing lymphocytes as well as other non- 
Ig-bearing cells (10). Ig-bearing (B) cells are retained and may be subsequently 
eluted  from  the  column  by washing  with  medium  containing  normal  mouse 
serum. The cell recovery from these columns is excellent (95-100 %) and these 
cells are functional as shown by their activity in culture. 
The T  and B  cells obtained by this column fractionation procedure were cul- 
tured and their immunocompetence determined (Table IV). Groups A  through 
D  are controls showing that anti-/~ and C-treated normal spleen cells, irradiated 
GAT-MBSA-primed spleen cells, and column-purified T  and B  cells did not de- 
velop GAT-specific PFC  responses to  GAT-MBSA when  cultured separately. 
The B- and T-cell sources used for reconstitution are shown to be competent in 
group E. Column purified T  and B  cells cultured together developed a PFC re- 
sponse  to  SRBC  (group  F)  but  failed to  develop a  significant  GAT-specific 
PFC response to GAT-MBSA (group G). 
Column-purified  T  cells  from  GAT-primed  mice  were  unable  to  provide 
helper function to normal B cells (group H). However, B  cells from GAT-primed 
mice responded very well to  GAT-MBSA when  cultured with  carrier-primed 
helper T  cells (group I). This experiment again demonstrates that unresponsive- 
ness induced by injection of GAT in vivo is not  due  to B-cell tolerance, but 
rather  to a  failure of the T  cells to provide helper function for  the B-cell re- 
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Column-purified  T  and  B  cells from  GAT-primed DBA/1 mice were also 
examined for suppressive activity on cultures of spleen cells from normal DBA/1 
mice  (Table V). As demonstrated  earlier,  the spleen  cells from  GAT-primed 
mice failed to respond to GAT-MBSA in vitro (group C)  and suppressed the 
immune response of normal spleen cells to GAT-MBSA (group B compared to 
group D). Suppressor cell activity was present in the fraction containing T cells 
(group F), but was not present in the B-cell fraction (group G). 
Antigen Specificity of Suppressor  T Cells.--Data presented in the experiments 
thus far have shown that the generation of suppressor cells in nonresponder mice 
TABLE  IV 
Characterization of Column-Purified B and T Cdls from GA T-Primed DB  A /1 Mice 
DBA/I spleen cells  IgG PFC/culture* 
GAT-primed  Exp. 1  Exp. 2 
column-purified§  Antigen  Group  107 Normal  107 X- 
treated with  irradiated 
GAT-MBSA 
ant§q9 and C  primed$  5 X  10  6B  5 X  10  6T  SRBC  GAT  SRBC  GAT 
A  +  -  -  -  GAT-MBSA  --  < t0  --  < 10 
B  --  +  --  --  GAT-MBSA  --  35  --  < 10 
C  --  --  +  --  GAT-MBSA  --  < l0  --  < 10 
D  --  --  --  +  GAT-MBSA  --  <10  --  <10 
E  +  +  --  --  GAT-MBSA  --  1,080  --  1,375 
F  --  --  +  +  SRBC  585  --  1,ooo  -- 
G  --  --  +  +  GAT-MBSA  --  50  --  40 
H  +  --  --  +  GAT-MBSA  -  15  -  < 10 
I  -  +  +  -  GAT-MBSA  --  1,255  --  785 
* Cultures harvested after incubation with 107 SRBC or 5 #g GAT as GAT-MBSA for 5 days. 
:~ Mice primed with GAT-MBSA containing 10/~g GAT 60 days before irradiation (800 R) and sacrifice. 
§ Mice primed with 10pg GAT in Maalox 3 days before sacrifice. Column-purified splenic B cells: exp. 1,  85% 
Ig bearing and exp, 2, 96% Ig bearing. Column-purified splenic T  cells: exp.  1,  7% Ig bearing and  exp. 2, 0% Ig 
bearing. 
TABLE  V 
Suppressive Activity of Column-Purified T Cells  from GA T-Primed  DBA /1Mice 
DBA/1 spleen cells 
Group  10  7  GAT-  GAT-primed  column-purified§  Antigen 
10  7  Normal  primed$ 
IgG  GAT- 
specific 
PFC/culture* 
5X 10  sB  5 X 10  6T  Exp. l Exp. 2 
A  +  --  --  --  GAT  <10  <10 
B  +  --  --  --  GAT-MBSA  515  600 
C  --  +  --  --  GAT-MBSA  15  35 
D  +  +  --  --  GAT-MBSA  105  10 
E  --  --  +  +  GAT-MBSA  50  40 
F  +  --  --  +  GAT-MBSA  <  10  35 
G  +  --  +  --  GAT-MBSA  935  725 
*  Cultures  harvested  after incubation  with  5  #g  GAT  or 5/zg  GAT  as  GAT-MBSA  for 5 
days. 
Mice primed with  10 #g GAT  in Maalox  3  days before sacrifice. 
§ Column-purified  cells from  the same cell suspension  as described in (5)  and  as described 
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depends upon previous exposure to GAT. The findings that mice injected with 
GAT fail to respond to a subsequent challenge with GAT-MBSA, but  respond 
normally to a  subsequent  injection of SRBC  (6)  and that cultures  containing 
GAT-induced suppressor  cells  are nevertheless  able to respond  to SRBC  sug- 
gests,  but  does not prove,  that  the  suppression  is  antigen  specific.  Since  the 
demonstration of suppression  involves exposure  to GAT-MBSA, it is  possible 
that  GAT-MBSA may be  required  to  induce  active  suppressors  in  cultured 
spleen cells from mice previously primed with GAT. Therefore,  the  specificity 
of the suppressive  activity must be examined by the  addition  of both  GAT- 
MBSA and SRBC to cultures containing normal and GAT-primed spleen cells. 
Such an experiment is presented in Table VI. All spleen cell cultures responded 
TABLE VI 
Antigen  Specificity of Suppressor T Cells 
DBA/I spleen cells  IgG PFC/cultnre* 
Group  Antigen 
107 Normal  107 GAT-primedl:  SRBC  GAT 
A  +  --  GAT-MBSA  --  525 
B  --  +  GAT-MBSA  --  10 
C  +  +  GAT-MBSA  --  < 10 
D  +  --  SRBC  250  -- 
E  --  +  SRBC  530  - 
F  +  +  SRBC  640  -- 
G  +  --  SRBC and 
GAT-MBSA  470  -- 
H  +  +  SRBC and 
GAT-MBSA  635  -- 
* Cultures harvested  after 5 days incubation with 107 SRBC or GAT-MBSA containing 
5 #g GAT or both. 
J~ Mice primed with 10 #g GAT in Maalox 11 days before sacrifice and culture initiation. 
to SRBC  and  GAT-primed spleen  cells  did not inhibit  the normal spleen  cell 
response  to SRBC  (group F).  Addition of GAT-MBSA to cultures  of normal 
spleen cells stimulated by SRBC did not inhibit the development of anti-SRBC 
PFC responses (group G) nor was this response inhibited if GAT-primed spleen 
cells  were present  (group H). Therefore,  the suppressor  cells  elicited by GAT 
inhibit only GAT-specific B-cell responses. 
DISCUSSION 
The data in these experiments demonstrate that: 
(a)  Treatment of nonresponder DBA/1 mice with GAT renders their spleen 
cells  unable  to  develop  a  GAT-specific response  when  incubated  with  GAT- 
MBSA, although their response to SRBC is  equivalent  to that of spleen  cells 
from  normal  DBA/1  mice.  B  cells  from  GAT-primed  mice  can  respond  to 
GAT-MBSA in vitro  in  the  presence  of added  carrier-primed  (GAT-MBSA) 
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cell,  the GAT-specific response of nonresponder B cells in the presence of (re- 
sponder  X  nonresponder)F1GAT-primed T  cells  to  GAT-MBSA  and macro- 
phage-bound GAT could be inhibited if soluble GAT was added to the cultures. 
Thus, nonresponder B cells, in the presence of GAT, are less able than responder 
B cells to cooperate with F1 helper T cells. However, it has been shown that in- 
teraction with GAT does not permanently inactivate these B  cells.  Once re- 
moved from the presence of soluble GAT, these B cells become responsive again, 
perhaps by capping and endocytosing bound GAT and regenerating membrane 
receptors. This possibility is currently being investigated. Thus, the failure of 
GAT-primed spleen cells to respond to GAT-MBSA in vitro cannot be attrib- 
uted to B-cell tolerance. This unresponsiveness is rather the result of impaired 
carrier-specifc helper T-cell function in GAT-primed spleen cell suspensions. 
(b)  Spleen cells from GAT-primed DBA/1 mice specifically suppress the de- 
velopment of GAT-specific PFC responses by spleen cells from normal DBA/1 
mice incubated with GAT-MBSA. This suppression is prevented by treatment 
of GAT-primed spleen cells with anti-0 serum and C or by exposure to 800 R 
X  irradiation. The activity of suppressor T  cells can be overcome by the addi- 
tion of adequate numbers of carrier-primed helper T  cells. This suggests that 
competition may exist between the activities of helper and suppressor T cells. 
(c)  The activity of suppressor T cells induced by GAT is antigen specific. The 
specificity was determined by the observation that addition of spleen cells from 
GAT-primed  DBA/1  mice  and  GAT-MBSA  to  cultures  of normal  DBA/1 
spleen cells did not inhibit the PFC response stimulated by SRBC but did in- 
hibit the GAT-specific response to GAT-MBSA. These findings are in agree- 
ment with the hypothesis of Gershon et al. (13), which postulated the generation 
of suppressor T cells in nonresponder animals injected with GAT. 
An important question to resolve concerns  the mechanism and the site of 
action of suppressor T  cells in the GAT system. In several other systems where 
they have been demonstrated, suppressor T cells have been shown to exert their 
effects on the generation of helper T  cells or on T  cells which mediate delayed 
hypersensitivity reactions (14, 15). The results of our experiments do not per- 
mit us  to  distinguish whether  the  suppressor  T  cells  generated  by  GAT  in 
DBA/1 mice act on GAT-specific B cells or on MBSA (carrier)-specific helper 
T  cells  which by binding GAT-MBSA  could be  susceptible  to  GAT-specific 
suppression. This issue may be resolved by investigating whether the suppressor 
T cells generated by GAT can also suppress the antibody response to MBSA in 
GAT-MBSA-immunized animals. 
With respect to mechanism of action, the suppressor T cells may act by direct 
cell contact or through the release of an active product. If the latter is true, the 
demonstration that the suppressor activity is antigen-specific implies that this 
product must combine both suppressor and specificity properties. 
The demonstration that nonresponder mice injected with GAT, the response 
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and become specifically unresponsive  to a  subsequent  challenge  with GAT- 
MBSA  and that this unresponsiveness  is the result of an active suppressive 
process mediated by T cells, raises important questions concerning the mecha- 
nism of Ir-gene regulation of the immune response. The first relevant issue is 
whether the generation of suppressor T cells in nonresponder mice is unique to 
this system or may be generalized to other systems and species where the re- 
sponse to the antigen is under the control of histocompatability-linked  Ir genes. 
What are the implications of the demonstration of GAT-specific suppressor T 
cells in nonresponder  animals for the function of Ir genes and their products? 
There are at least three interpretations of the role of Ir genes which could ac- 
count for these observations. First, one could postulate that both responder and 
nonresponder mice can develop both helper and suppressor T cells, but that the 
sensitivity of B cells to these T-cell activities is inherently different in responder 
and nonresponder  mice. Nonresponder  B cells would be more sensitive to sup- 
pressor  T-cell activity, thus any GAT-specific helper  T-cell  activity in these 
mice would be undetectable. However, in data to be published:  (a) we have not 
detected GAT-specific helper  function in  spleens of irradiated  GAT-primed 
nonresponder  mice for responder  F1 B cells exposed to GAT-MBSA;  (b)  nor 
have we been able to demonstrate that T  cells from GAT-primed,  irradiated 
nonresponder  animals could cooperate  with syngeneic nonresponder  B cells in 
a response  to macrophage-bound  GAT. However,  evaluation of the effect of 
various ratios of helper  to suppressor T  cells cultured with responder or non- 
responder B cells should permit this possibility to be directly explored. 
The second possibility is that suppressor T cells are a normal component of 
all immune responses, as suggested by the data of Tada and Takemori (16, 17) 
but that Ir genes determine the presence or absence of helper T  cells specific 
for the antigen and are not involved in the regulation of suppressor cells. How- 
ever, since GAT specifically induces suppressor  T cells in nonresponders,  it is 
then necessary to postulate two separate,  antigen-specific recognition  systems 
for helper  and suppressor  T  cells, respectively,  the former one under Ir-gene 
control. 
The third model to be considered also assumes that suppressor T cells are a 
normal component of the immune system. Rather than proposing two different 
T-cell populations  and/or two different  antigen-recognition  systems as in the 
second model, we can consider that responder T cells have the potential of de- 
veloping into helper or suppressor  cells. The manner of interaction of antigen 
with the GAT-specific T-cell receptor  would select  the pathway to helper  or 
suppressor  cell activity. On the other hand, interaction  of antigen  with the 
GAT-specific T-cell receptor  on nonresponder  T cells results in development of 
only suppressor cells. Thus, Ir genes would behave as regulator genes, perhaps 
coding for specific antigen receptors  and through these receptors  determining 
the function of T cells after interactions with antigen or perhaps by controlling 
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SUMMARY 
In recent  studies  we have found that  GAT  not only fails  to elicit  a GAT-spe- 
cific  response in nonresponder mice but also  specifically  decreases  the ability  of 
nonresponder mice to develop a GAT-specific PFC  response to a subsequent 
challenge with GAT  bound to the immunogenic carrier,  MBSA.  Studies  pre- 
sented in this paper demonstrate that B cells from nonresponder, DBA/1 mice 
rendered unresponsive by GAT in vivo can respond in vitro to GAT-MBSA if 
exogenous, carrier-primed T  cells are added to the cultures. The unresponsive- 
ness was shown to be the result of impaired carrier-specific helper T-cell func- 
tion in the spleen cells of GAT-primed mice. 
Spleen cells from GAT-primed mice specifically suppressed the GAT-specific 
PFC response of spleen cells from normal DBA/1 mice incubated with GAT- 
MBSA. This suppression was prevented by pretreatment of GAT-primed spleen 
cells with anti-0 serum plus C or X  irradiation. Identification of the suppressor 
cells as T  cells was confirmed by the  demonstration that suppressor cells were 
confined to the fraction of the column-purified lymphocytes which contained 
0-positive cells and a few non-Ig-bearing cells. The significance of these data to 
our understanding of Ir-gene regulation of the immune response is discussed. 
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